Koh Fujinaga

4.7k total citations
72 papers, 3.5k citations indexed

About

Koh Fujinaga is a scholar working on Virology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Koh Fujinaga has authored 72 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Virology, 46 papers in Molecular Biology and 23 papers in Infectious Diseases. Recurrent topics in Koh Fujinaga's work include HIV Research and Treatment (48 papers), RNA Research and Splicing (24 papers) and HIV/AIDS drug development and treatment (21 papers). Koh Fujinaga is often cited by papers focused on HIV Research and Treatment (48 papers), RNA Research and Splicing (24 papers) and HIV/AIDS drug development and treatment (21 papers). Koh Fujinaga collaborates with scholars based in United States, Japan and Germany. Koh Fujinaga's co-authors include B. Matija Peterlin, Ran Taube, David H. Price, Dan Irwin, Thomas P. Cujec, Koen Bartholomeeusen, Daniele C. Cary, Yanhui Xiang, Ye-Hong Huang and Edward A. Sausville and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Koh Fujinaga

72 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Koh Fujinaga United States 32 2.2k 1.6k 773 716 447 72 3.5k
Bijan Sobhian France 16 2.4k 1.1× 1.3k 0.8× 559 0.7× 1000 1.4× 571 1.3× 19 3.7k
Anna Cereseto Italy 34 2.1k 1.0× 848 0.5× 609 0.8× 1.2k 1.7× 751 1.7× 72 3.9k
Rosemary Kiernan France 19 1.8k 0.8× 1.1k 0.7× 572 0.7× 523 0.7× 312 0.7× 33 2.6k
Bernard Krust France 31 1.7k 0.7× 1.2k 0.7× 555 0.7× 983 1.4× 467 1.0× 66 3.3k
Н. П. Шарова Russia 19 1.3k 0.6× 1.4k 0.9× 871 1.1× 517 0.7× 185 0.4× 66 2.7k
Wolfgang Resch United States 27 2.9k 1.3× 664 0.4× 338 0.4× 1.1k 1.5× 558 1.2× 40 4.3k
Liwei Rong Canada 20 1.5k 0.7× 710 0.4× 478 0.6× 684 1.0× 190 0.4× 30 2.3k
Yves Collette France 36 1.7k 0.7× 776 0.5× 386 0.5× 1.5k 2.0× 621 1.4× 90 3.6k
Betty Poon United States 22 1.1k 0.5× 1.2k 0.8× 630 0.8× 626 0.9× 187 0.4× 33 2.1k
T. Jesse Kwoh United States 22 1.3k 0.6× 660 0.4× 404 0.5× 380 0.5× 294 0.7× 41 2.4k

Countries citing papers authored by Koh Fujinaga

Since Specialization
Citations

This map shows the geographic impact of Koh Fujinaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koh Fujinaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koh Fujinaga more than expected).

Fields of papers citing papers by Koh Fujinaga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koh Fujinaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koh Fujinaga. The network helps show where Koh Fujinaga may publish in the future.

Co-authorship network of co-authors of Koh Fujinaga

This figure shows the co-authorship network connecting the top 25 collaborators of Koh Fujinaga. A scholar is included among the top collaborators of Koh Fujinaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koh Fujinaga. Koh Fujinaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuzmina, Alona, M. Hasanuzzaman, Koh Fujinaga, et al.. (2024). Direct and indirect effects of CYTOR lncRNA regulate HIV gene expression. PLoS Pathogens. 20(4). e1012172–e1012172. 2 indexed citations
2.
Li, Yang, et al.. (2024). Enhanced NF-κB activation via HIV-1 Tat-TRAF6 cross-talk. Science Advances. 10(3). eadi4162–eadi4162. 19 indexed citations
3.
Fujinaga, Koh, Fang Huang, & B. Matija Peterlin. (2023). P-TEFb: The master regulator of transcription elongation. Molecular Cell. 83(3). 393–403. 70 indexed citations
4.
Huang, Fang, Yongmei Feng, B. Matija Peterlin, & Koh Fujinaga. (2022). P-TEFb is degraded by Siah1/2 in quiescent cells. Nucleic Acids Research. 50(9). 5000–5013. 6 indexed citations
5.
Huang, Fang, et al.. (2022). DCAF1 inhibits the NF-κB pathway by targeting p65. Immunology Letters. 249. 33–42. 5 indexed citations
6.
Leoz, Marie, Petra Kukanja, Zeping Luo, et al.. (2018). HEXIM1-Tat chimera inhibits HIV-1 replication. PLoS Pathogens. 14(11). e1007402–e1007402. 17 indexed citations
7.
Xiang, Yanhui, Koh Fujinaga, Koen Bartholomeeusen, et al.. (2014). Release of Positive Transcription Elongation Factor b (P-TEFb) from 7SK Small Nuclear Ribonucleoprotein (snRNP) Activates Hexamethylene Bisacetamide-inducible Protein (HEXIM1) Transcription. Journal of Biological Chemistry. 289(14). 9918–9925. 40 indexed citations
8.
Bartholomeeusen, Koen, Yanhui Xiang, Koh Fujinaga, & B. Matija Peterlin. (2012). Bromodomain and Extra-terminal (BET) Bromodomain Inhibition Activate Transcription via Transient Release of Positive Transcription Elongation Factor b (P-TEFb) from 7SK Small Nuclear Ribonucleoprotein. Journal of Biological Chemistry. 287(43). 36609–36616. 154 indexed citations
9.
Kuzmina, Alona, Uzi Hadad, Koh Fujinaga, & Ran Taube. (2012). Functional characterization of a human cyclin T1 mutant reveals a different binding surface for Tat and HEXIM1. Virology. 426(2). 152–161. 2 indexed citations
10.
Toossi, Zahra, Mianda Wu, Christina S. Hirsch, et al.. (2011). Activation of P-TEFb at Sites of Dual HIV/TB Infection, and Inhibition of MTB-Induced HIV Transcriptional Activation by the Inhibitor of CDK9, Indirubin-3′-Monoxime. AIDS Research and Human Retroviruses. 28(2). 182–187. 12 indexed citations
11.
Grol, Jennifer Van, Rosa M. Andrade, Koh Fujinaga, et al.. (2010). HIV-1 Inhibits Autophagy in Bystander Macrophage/Monocytic Cells through Src-Akt and STAT3. PLoS ONE. 5(7). e11733–e11733. 109 indexed citations
12.
Imai, Kenichi, Kaori Asamitsu, Ann Florence B. Victoriano, et al.. (2009). Cyclin T1 stabilizes expression levels of HIV‐1 Tat in cells. FEBS Journal. 276(23). 7124–7133. 15 indexed citations
13.
Ogba, Ndiya, et al.. (2008). HEXIM1 Regulates 17β-Estradiol/Estrogen Receptor-α–Mediated Expression of Cyclin D1 in Mammary Cells via Modulation of P-TEFb. Cancer Research. 68(17). 7015–7024. 27 indexed citations
14.
Tobiume, Minoru, Koh Fujinaga, Satoko Suzuki, et al.. (2002). Extracellular Nef Protein Activates Signal Transduction Pathway from Ras to Mitogen-Activated Protein Kinase Cascades That Leads to Activation of Human Immunodeficiency Virus from Latency. AIDS Research and Human Retroviruses. 18(6). 461–467. 17 indexed citations
15.
Chao, Sheng‐Hao, Koh Fujinaga, Ran Taube, et al.. (2000). Flavopiridol Inhibits P-TEFb and Blocks HIV-1 Replication. Journal of Biological Chemistry. 275(37). 28345–28348. 389 indexed citations
16.
Fujinaga, Koh, Ran Taube, Thomas P. Cujec, et al.. (1999). Interactions between Tat and TAR and Human Immunodeficiency Virus Replication Are Facilitated by Human Cyclin T1 but Not Cyclins T2a or T2b. Virology. 255(1). 182–189. 71 indexed citations
17.
Fujinaga, Koh, et al.. (1999). Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T. Proceedings of the National Academy of Sciences. 96(4). 1285–1290. 114 indexed citations
18.
Nakaya, Takaaki, Shigenori Iwai, Koh Fujinaga, E. Otsuka, & Kazuyoshi Ikuta. (1997). Inhibition of HIV-1 replication by targeting the Rev protein.. 20. 106–109. 5 indexed citations
19.
Fujinaga, Koh, et al.. (1996). E Growth dominance of a revertant virus generated during in vitro serial passage of nef frameshift mutant of HIV-1.. 19. 89–94. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bijan Sobhian Breakdown of academic impact, for papers by Anna Cereseto Breakdown of academic impact, for papers by Rosemary Kiernan Breakdown of academic impact, for papers by Bernard Krust Breakdown of academic impact, for papers by Н. П. Шарова Breakdown of academic impact, for papers by Wolfgang Resch Breakdown of academic impact, for papers by Liwei Rong Breakdown of academic impact, for papers by Yves Collette Breakdown of academic impact, for papers by Betty Poon Breakdown of academic impact, for papers by T. Jesse Kwoh
Rankless by CCL
2026